Tıbbi Sülük Hirudo medicinalis L., 1758 Üzerinde Bakır Sülfatın (CuSO45 H2O) Akut Toksisitesinin Araştırılması.

by Naim Sağlam, Ayşegül Şahi̇n
Published 2006-03-01

Acut toxicity of cupper sulphate (CuSO4. 5 H2O) on medical leech Hirudo medicinalis L . 1758.

by Naim Sağlam, Ayşegül Şahin
Published 2006-03-01

Tıbbi Sülük Hirudo medicinalis L., 1758 Üzerinde Bakır Sülfatın (CuSO45 H2O) Akut Toksisitesinin Araştırılması.

by Naim Sağlam, Ayşegül Şahin
Published 2006-03-01

Tıbbi Sülük Hirudo medicinalis L., 1758 Üzerinde Bakır Sülfatın (CuSO45 H2O) Akut Toksisitesinin Araştırılması.

by Naim Sağlam, Ayşegül Şahin
Published 2015-12-01

Tıbbi Sülük Hirudo medicinalis L., 1758 Üzerinde Bakır Sülfatın (CuSO45 H2O) Akut Toksisitesinin Araştırılması.

by Ayşegül Şahin, Naim Sağlam
Published 2006-03-01

The Effect of Physical Activity Level and Sleep Quality on Quality of Life in Pregnant Women

by Alis Kostanoğlu, Ayşe Sena Manzak, Ayşegül Şahin
Published 2019-09-01

Şizofrenide Psikojenik Polidipsi için Amisülpirid Tedavisi: Olgu Sunumu

by Ayşegül ŞAHİN EKİCİ, Şengül ŞAHİN, Gülçin ELBOĞA, Abdurrahman ALTINDAĞ
Published 2019-04-01

Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.

by Patricia A Thompson, Abenaa M Brewster, Do Kim-Anh, Veerabhadran Baladandayuthapani, Bradley M Broom, Mary E Edgerton, Karin M Hahn, James L Murray, Aysegul Sahin, Spyros Tsavachidis, Yuker Wang, Li Zhang, Gabriel N Hortobagyi, Gordon B Mills, Melissa L Bondy
Published 2011-01-01

Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1.

by Carolina J Jorgez, Jill A Rosenfeld, Nathan R Wilken, Hima V Vangapandu, Aysegul Sahin, Dung Pham, Claudia M B Carvalho, Anne Bandholz, Amanda Miller, David D Weaver, Barbara Burton, Deepti Babu, John S Bamforth, Timothy Wilks, Daniel P Flynn, Elizabeth Roeder, Ankita Patel, Sau W Cheung, James R Lupski, Dolores J Lamb
Published 2014-01-01

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Published 2015-01-01

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Published 2016-01-01

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

by Yan Xing, Nancy U. Lin, Matthew A. Maurer, Huiqin Chen, Armeen Mahvash, Aysegul Sahin, Argun Akcakanat, Yisheng Li, Vandana Abramson, Jennifer Litton, Mariana Chavez-MacGregor, Vicente Valero, Sarina A. Piha-Paul, David Hong, Kim-Anh Do, Emily Tarco, Dianna Riall, Agda Karina Eterovic, Gerburg M. Wulf, Lewis C. Cantley, Gordon B. Mills, L. Austin Doyle, Eric Winer, Gabriel N. Hortobagyi, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Published 2019-07-01